Affiliation:
1. St. Michael's Hospital Toronto, Canada
2. University of Toronto Toronto, Canada
Abstract
This case illustrates a pharmacokinetic interaction between the tricyclic antidepressant, nortriptyline, and the antituberculosis drug, rifampin. Higher than expected doses of nortriptyline were required to obtain a therapeutic drug level while the patient was receiving rifampin. Following the discontinuation of rifampin, the patient became drowsy and the serum nortriptyline levels rose precipitously into the toxic range. The authors suggest that patients receiving rifampin and nortriptyline, (or other psychotropic drugs) be monitored closely and that similar drug interactions be anticipated.
Subject
Psychiatry and Mental health
Reference11 articles.
1. Ciraulo D. A., Shader R. I., Greenblatt B. J ., Creelman W., Drug Interactions in Psychiatry, Fisher M. G. (ed.), Williams and Wilkins, Baltimore, Maryland, pp. 21–53, 1989.
2. CHANGES IN CORTISOL METABOLISM FOLLOWING RIFAMPICIN THERAPY
3. Effect of rifampicin.treatment on the metabolism of oestradiol and 17?-ethinyloestradiol by human liver microsomes
4. RIFAMPICIN AND DRUG METABOLISM
5. Inhibition by Rifampin of the Anticoagulant Effect of Phenprocoumon
Cited by
20 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献